MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WSS E V has a total of 40 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2008. It filed its patents most often in United States, Hungary and Slovenia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are UNIV GLASGOW, MAX PLANCK GESELLSCHAFT and UNIV KEIO.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 23 | |
#2 | Hungary | 5 | |
#3 | Slovenia | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | EAPO (Eurasian Patent Organization) | 1 | |
#8 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Optics | |
#5 | Semiconductors | |
#6 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Kaufmann Stefan H E | 5 |
#2 | Grode Leander | 5 |
#3 | Bandermann Silke | 5 |
#4 | Bamberg Ernst | 4 |
#5 | Seeberger Peter H | 4 |
#6 | Teshima Masahiro | 3 |
#7 | Hell Stefan W | 3 |
#8 | Mirzoyan Razmik | 3 |
#9 | Desel Christiane | 3 |
#10 | Mager Thomas | 2 |
Publication | Filing date | Title |
---|---|---|
US2016137724A1 | Antibodies for prevention and treatment of diseases caused by clostridium difficile | |
US2015202451A1 | Multisite heart pacing with adjustable number of pacing sites for terminating high frequency cardiac arrhythmias | |
US2015206341A1 | Method for providing a three dimensional body model | |
US2014068813A1 | Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof | |
US2015022892A1 | Method of producing a Fresnel Zone Plate for applications in high energy radiation | |
CA2769121A1 | Highly efficient cmos technology compatible silicon photoelectric multiplier |